Ssu-Chuan Lai
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Ssu-Chuan Lai
Earlier roles on record: Chairman, CFO and CEO at Vitaspring Biomedical Co. Ltd. (VSBC) until September 7, 2026. Vitaspring Biomedical Co. Ltd. reported in an 8-K filed September 10, 2026 that Ssu-Chuan Lai resigned as member of the Board, effective September 7, 2026. Vitaspring Biomedical Co. Ltd. reported in an 8-K filed September 10, 2026 that Ssu-Chuan Lai resigned as President, effective September 7, 2026. Vitaspring Biomedical Co. Ltd. reported in an 8-K filed September 10, 2026 that Ssu-Chuan Lai resigned as Chief Financial Officer, effective September 7, 2026. Equibles holds 8 filed executive changes naming Ssu-Chuan Lai; each is listed under recent activity with its source filing.
“Effective at 11:58 p.m. Pacific Time on September 7, 2026, immediately following the election of her successor as a director and the appointment of her successor officers as described in Items 5.02(c) and (d) below, Dr. Ssu-Chuan Lai resigned from her positions as Chairperson of the Board, Chief Executive Officer, President, Chief Financial Officer, and Secretary of the Company, and as a member of the Board.”
“Effective at 11:58 p.m. Pacific Time on September 7, 2026, immediately following the election of her successor as a director and the appointment of her successor officers as described in Items 5.02(c) and (d) below, Dr. Ssu-Chuan Lai resigned from her positions as Chairperson of the Board, Chief Executive Officer, President, Chief Financial Officer, and Secretary of the Company, and as a member of the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2025-08-07–2026-09-07
-
2025-08-07–2026-09-07
-
2025-08-07–2026-09-07
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.